Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 9:30 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1201–1224 of 13,937 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Intraventricular Hemorrhage of Prematurity
Interventions: Tortle Midliner; Device
Lead sponsor: Orlando Health, Inc.; Other
Eligibility: Up to 31 Weeks
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Sleep Disorder, Restless Legs Syndrome
Interventions: Istradefylline (KW-6002); Drug
Lead sponsor: Kyowa Kirin, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Infection; Cesarean Section, Surgical Wound Infection, Endometritis
Interventions: 80% inhaled oxygen via non-rebreather mask, 30% inhaled oxygen via nasal cannula; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 12 Years to 50 Years · Female only
Enrollment: 606 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obesity, Infection; Cesarean Section, Surgical Wound
Interventions: Midline Vertical, High Transverse; Procedure
Lead sponsor: Albany Medical College; Other
Eligibility: Female only
Enrollment: 309 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 6
States / cities: Albany, New York • Ballston Spa, New York • Clifton Park, New York + 2 more

Conditions: Advanced Soft-tissue Sarcoma, Advanced Epithelioid Sarcoma
Interventions: Tazemetostat, Doxorubicin HCl; Drug
Lead sponsor: Epizyme, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 18
States / cities: Duarte, California • Santa Monica, California • Aurora, Colorado + 13 more

Conditions: Parkinson's Disease
Interventions: carbidopa; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 35 Years to 85 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Anxiety, Depression, Stress, Burnout, Emotion Regulation, Social Acceptance, Loneliness, Compassion
Interventions: Compassion Cultivation Training (CCT), Mindfulness-Based Stress Reduction (MBSR); Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 290 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell Tumor
Interventions: moxifloxacin hydrochloride, Placebo; Drug
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years to 120 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Seasonal Affective Disorder
Interventions: Negative Ion Generator, Light-emitting Photodiode light treatment device; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 3
States / cities: New Haven, Connecticut • Rockville, Maryland • Belmont, Massachusetts

Conditions: Pneumococcal Infections
Interventions: Multivalent, 13vPnC; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 42 Days to 98 Days
Enrollment: 460 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 39
States / cities: Fayetteville, Arkansas • Downey, California • Huntington Beach, California + 29 more

Conditions: End Stage Liver Disease
Interventions: Advance Care Planning Video Decision Support Tool, Verbal Narrative; Behavioral · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acne
Interventions: The Zeltiq System; Device
Lead sponsor: Zeltiq Aesthetics; Industry
Eligibility: 18 Years to 25 Years · Male only
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Shift-Work Sleep Disorder, Shift-Work Related Sleep Disturbance
Interventions: 8-h Afternoon-Evening Sleep, 8-h Free Sleep; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 50 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Alcohol Use Disorder
Interventions: Pregabalin, Placebo; Drug · Other
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Self-Control
Interventions: Cold-Pressor Task (CPT), Trier Social Stress Test (TSST), Modified Non-Stress CPT, Modified Non-Stress TSST, Functional Magnetic Resonance Imaging (fMRI); Behavioral · Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 70 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Lumbar Spinal Stenosis
Interventions: Liposomal bupivacaine; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Colorectal Cancer
Interventions: Mailed printed materials and in-office training; Behavioral
Lead sponsor: Georgetown University; Other
Eligibility: 50 Years to 74 Years
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Philadelphia, Pennsylvania

Conditions: Knee Pain
Interventions: Botulinum toxin A, Normal Saline; Drug
Lead sponsor: Minneapolis Veterans Affairs Medical Center; Federal
Eligibility: Not listed
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Idiopathic Intracranial Hypertension (IIH)
Interventions: Tirzepatide, Tirzepatide Placebo; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Parkinson's Disease
Interventions: VY-AADC02, Sham (Placebo) Surgery; Biological · Other
Lead sponsor: Neurocrine Biosciences; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 11
States / cities: Irvine, California • Sacramento, California • San Francisco, California + 8 more

Conditions: Acute Ischemic Stroke
Interventions: Argatroban, Eptifibatide, Placebo; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 514 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 61
States / cities: Birmingham, Alabama • Fullerton, California • La Jolla, California + 47 more

Conditions: Asthma in Children
Interventions: Social Media Enhanced Education, Usual Asthma Education; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 3 Years to 17 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Gestational Diabetes Mellitus (GDM)
Interventions: Fiber; Dietary Supplement
Lead sponsor: Eastern Virginia Medical School; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Kidney Disease
Interventions: Mezagitamab, Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 347 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 45
States / cities: Birmingham, Alabama • Montgomery, Alabama • Surprise, Arizona + 38 more

Search by objective public record fields.

Tortle Midliner and Intraventricular Hemorrhage

Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome

Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity

Skin Incisions and Wound Complication Rates for C-sections in Obese Women

Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma

High and Low Dose Carbidopa Treatment of Parkinson's Disease

Compassion Training and Mindfulness Training for Social Well-Being and Mental Health

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

A Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD)

Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants

A Randomized Controlled Trial of an Advanced Care Planning Video Decision Support Tool for Patients With End-Stage Liver Disease

A Pilot Clinical Trial Investigating the Effect of Cutaneous Cooling on Sebum Production

Sleep and Circadian Treatments for Shift Workers

Pregabalin Trial for the Treatment of Alcohol Use Disorder

Stress & Self-Control Costs

Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine

A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese

Safety and Efficacy of Botulinum Toxin A Injection in Patients With Painful Artificial Knee Arthroplasty (TKA)

Tirzepatide in Idiopathic Intracranial Hypertension Trial

VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)

Multi-arm Optimization of Stroke Thrombolysis

Using Social Media to Decrease Healthcare Utilization for Pediatric Asthma

Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy